Key Information
Source
summary/abstract
The utility of heart‐type fatty acid binding protein (H‐FABP) as a prognostic biomarker in light chain cardiac amyloidosis (AL‐CA) patients remains unestablished. Consecutive patients diagnosed with AL‐CA in the Heart Failure Center; Fuwai Hospital were enrolled. Baseline H‐FABP levels categorized patients as low (≤ 9.5 ng/mL) or high (> 9.5 ng/mL) group. Kaplan–Meier analysis and Cox proportional hazards models were performed. Model performance was assessed using Harrell's C concordance index (C‐index), integrated discrimination improvement (IDI) index, and net reclassification improvement (NRI) index. Eighty‐four patients were included (mean age 60.12 ± 11.25 years; 32.1% female), with 30 (35.7%) in the high H‐FABP group.